Erlanger (Chattanooga TN) May Add Cyberknife Cancer Treatment | ARAY Message Board Posts

Accuray Incorporated

  ARAY website

ARAY   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  4915 of 6350  at  12/16/2009 12:12:07 PM  by


Erlanger (Chattanooga TN) May Add Cyberknife Cancer Treatment, TN
December 15, 2009

Erlanger Medical Center is taking steps to add the Cyberknife cancer treatment program.

CyberKnife is a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body, including the prostate, lung, brain, spine, liver, pancreas and kidney, officials said.

The treatment delivers beams of high dose radiation to tumors with extreme accuracy, it was stated.

Despite its name, the CyberKnife treatment involves no cutting. It is described as "the worlds first and only robotic radiosurgery system designed to treat tumors throughout the body non-invasively. It provides a pain-free, non-surgical option for patients who have inoperable or surgically complex tumors, or who may be looking for an alternative to surgery."

Erlanger will be the only (exclusive) healthcare provider in the Tri State region offering this radiation oncology treatment.

Pat Charles, Erlanger spokesperson, said, "Because of its increased accuracy, the Cyberknife reduces the number of treatments (for inoperable tumors) from 30 to 40 treatments to 3-5, which is a huge benefit for those with cancerous tumors too difficult to treat with conventional radiation treatment.

"This will most definitely distinguish Erlanger's oncology program from others. And, best of all, having this device will eliminate the need for patients and families to travel outside the region for this treatment."

Erlanger earlier filed for a certificate of need along with Community Care, Inc to acquire a cyberknife and initiate cyberknife services/

The state has granted its approval at a cost not to exceed $7.3 million.

Erlanger's investment in the joint venture of $612,000 will be funded from the fiscal year 2009/10 capital budget.

     e-mail to a friend      printer-friendly     add to library      
Recs: 0  
   Views: 1119 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Financial Market Data provided by